We are live on
!
Find out more
Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$116B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
-1.66%
1 Year Est. Return
+26.37%
3 Year Est. Return
+67.38%
5 Year Est. Return
+85.79%
10 Year Est. Return
+313.78%
AUM
$153B
AUM Growth
+$152B
(+93,346%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
3,267
New
155
Increased
738
Reduced
2,125
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Amazon
AMZN
|
+$312M |
| 3 |
Enbridge
ENB
|
+$248M |
| 4 |
NextEra Energy
NEE
|
+$226M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$606M |
| 2 |
Linde
LIN
|
+$434M |
| 3 |
American Express
AXP
|
+$340M |
| 4 |
Cintas
CTAS
|
+$282M |
| 5 |
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.95% |
| 2 | Technology | 11.56% |
| 3 | Healthcare | 8.76% |
| 4 | Consumer Discretionary | 6.63% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
National CineMedia
NCMI
$249M
| $66.9K | ﹤0.01% |
2,633
+693
| +36% | +$19.3K |
|
|
PSTX
3002
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $65.5K | ﹤0.01% |
+14,614
| New | +$65.9K |
|
3003
Cytosorbents Corp
CTSO
$23.6M
| $65K | ﹤0.01% |
20,385
-5,076
| -20% | -$18.2K |
|
3004
INNOVATE Corp
VATE
$105M
| $64.8K | ﹤0.01% |
+1,755
| New | +$65.1K |
|
3005
Atossa Therapeutics
ATOS
$24.2M
| $64.6K | ﹤0.01% |
3,443
-936
| -21% | -$19K |
|
3006
Aveanna Healthcare
AVAH
$2.3B
| $64.3K | ﹤0.01% |
18,865
-4,568
| -19% | -$24.8K |
|
3007
Q32 Bio
QTTB
$466M
| $64.3K | ﹤0.01% |
1,175
-309
| -21% | -$19.2K |
|
|
LENZ
3008
LENZ Therapeutics
LENZ
$150M
| $64.2K | ﹤0.01% |
+1,799
| New | +$113K |
|
|
NMTR
3009
DELISTED
9 Meters Biopharma
NMTR
| $62.6K | ﹤0.01% |
5,221
-1,315
| -20% | -$18K |
|
|
SFT
3010
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $62.4K | ﹤0.01% |
2,836
-640
| -18% | -$14.2K |
|
|
SIEN
3011
DELISTED
Sientra, Inc.
SIEN
| $62.2K | ﹤0.01% |
2,801
-540
| -16% | -$14.8K |
|
3012
Alaunos Therapeutics
TCRT
$4.81M
| $61.1K | ﹤0.01% |
624
-201
| -24% | -$25.8K |
|
3013
CEL-SCI Corp
CVM
$25.5M
| $60.7K | ﹤0.01% |
515
-135
| -21% | -$22K |
|
|
ASXC
3014
DELISTED
Asensus Surgical, Inc.
ASXC
| $60.3K | ﹤0.01% |
96,234
-33,003
| -26% | -$25.4K |
|
|
EMKR
3015
DELISTED
Emcore Corp
EMKR
| $60K | ﹤0.01% |
1,621
+264
| +19% | +$12.6K |
|
|
ATHX
3016
DELISTED
Athersys, Inc. Common Stock
ATHX
| $59.7K | ﹤0.01% |
3,946
-1,066
| -21% | -$22.3K |
|
3017
Quantum Corp
QMCO
$935M
| $59.3K | ﹤0.01% |
1,306
-253
| -16% | -$18.5K |
|
|
HGEN
3018
DELISTED
HUMANIGEN, INC.
HGEN
| $59.3K | ﹤0.01% |
19,691
-5,415
| -22% | -$14.5K |
|
3019
Angi Inc
ANGI
$180M
| $57.3K | ﹤0.01% |
+1,011
| New | +$73.7K |
|
3020
Akebia Therapeutics
AKBA
$247M
| $56.5K | ﹤0.01% |
78,736
-20,212
| -20% | -$43.2K |
|
3021
Shattuck Labs
STTK
$747M
| $56.3K | ﹤0.01% |
13,211
-1,845
| -12% | -$10.5K |
|
3022
Cartesian Therapeutics
RNAC
$267M
| $53.2K | ﹤0.01% |
1,441
-273
| -16% | -$17.1K |
|
|
FRBK
3023
DELISTED
Republic First Bancorp Inc
FRBK
| $52.9K | ﹤0.01% |
+10,252
| New | +$49.3K |
|
3024
Olema Pharmaceuticals
OLMA
$913M
| $52.1K | ﹤0.01% |
12,234
-2,017
| -14% | -$11.1K |
|
|
CORR
3025
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $50K | ﹤0.01% |
16,297
+39
| +0.2% | +$135 |
|
Similar funds
VAM
Manulife (Manufacturers Life Insurance)'s Q1 2022 Portfolio in Review
As of Q1 2022, Manulife (Manufacturers Life Insurance) held 3,267 positions worth $153B, up 93,346% from $163M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Manulife (Manufacturers Life Insurance)'s Q1 2022 filing shows 155 new, 738 increased, 2,125 reduced and 210 closed positions. Its largest new stake was iShares MSCI Canada ETF: 3,413,430 shares worth $137M. The largest sale was Vanguard Morningstar Mid-Cap ETF, an estimated $606M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
- Manulife (Manufacturers Life Insurance)'s largest Q1 2022 buy was iShares MSCI Canada ETF: 3,413,430 shares worth $137M.
- Manulife (Manufacturers Life Insurance) added most to Microsoft in Q1 2022, an estimated $322M increase.
- Manulife (Manufacturers Life Insurance)'s biggest Q1 2022 reduction was Vanguard Morningstar Mid-Cap ETF, cutting an estimated $606M.
- Manulife (Manufacturers Life Insurance) fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q1 2022, selling an estimated $235M.
- Manulife (Manufacturers Life Insurance)'s ten largest holdings make up 31% of its $153B portfolio in Q1 2022.
- Manulife (Manufacturers Life Insurance) opened 155 new positions and closed 210 in Q1 2022.
- Manulife (Manufacturers Life Insurance)'s portfolio value rose 93,346% quarter-over-quarter to $153B.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.